Amyloid β, γ-secretase, and familial Alzheimer's disease

Affiliations

¹ Institut du Cerveau-Paris Brain Institute-ICM, Institut national de la santé et de la recherche médicale, Centre National de la Recherche Scientifique, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié Salpêtrière, Sorbonne Université, Paris 75013, France. Electronic address: marie-claude.potier@icm-institute.org.
² Biomedical Center, Division of Metabolic Biochemistry, Ludwig Maximilian University of Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany.
³ Vlaams Instituut voor Biotechnologie, Center for Brain and Disease Research, Katholieke Universiteit Leuven, Leuven, Belgium.

Marie-Claude Potier et al. Lancet Neurol. 2024 Sep.

. 2024 Sep;23(9):852-853.

doi: 10.1016/S1474-4422(24)00292-8. Epub 2024 Jul 26.

¹ Institut du Cerveau-Paris Brain Institute-ICM, Institut national de la santé et de la recherche médicale, Centre National de la Recherche Scientifique, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié Salpêtrière, Sorbonne Université, Paris 75013, France. Electronic address: marie-claude.potier@icm-institute.org.
² Biomedical Center, Division of Metabolic Biochemistry, Ludwig Maximilian University of Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany.
³ Vlaams Instituut voor Biotechnologie, Center for Brain and Disease Research, Katholieke Universiteit Leuven, Leuven, Belgium.

Erratum in

Correction to Lancet Neurol 2024; 23: 852-53.
[No authors listed] [No authors listed] Lancet Neurol. 2024 Sep;23(9):e13. doi: 10.1016/S1474-4422(24)00334-X. Lancet Neurol. 2024. PMID: 39152030 No abstract available.

No abstract available

LC-G was on an advisory board for Roche. HS received funding from Roche. M-CP declares no competing interests.